Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTt Electronics Regulatory News (TTG)

Share Price Information for Tt Electronics (TTG)

Share Price is delayed by 15 minutes
Get Live Data
116.60    -0.40 (-0.34%)
Bid:
116.60
Ask:
117.40
Spread: 0.80 (0.686%)
Market Cap: £208.00m
TTG Live PriceLast checked at - London Stock Exchange

Intraday Tt Electronics Share Chart

Trading Update

12 Nov 2020 07:00

RNS Number : 0489F
TT Electronics PLC
12 November 2020
 

 

 

12 November 2020

 

TT Electronics plc

 

In-line Trading Update

 

TT Electronics plc ("TT", "the Group"), a global provider of engineered electronics for performance critical applications, publishes the following Trading Update on the Group's performance in the four-month period ended 24 October 2020.

 

Improving revenue

 

Momentum in the Group's trading performance has continued as expected, with the trends in like-for-like revenue improving in the four months to October. Revenue in the period was 11 per cent lower than the previous year on a constant currency basis and 12 per cent lower on an organic1 basis. This compares to a 17 per cent organic reduction in the second quarter of 2020.

 

The trends previously seen in TT's end-markets have continued. Order intake has shown signs of recovery with bookings for the four months running at 104 per cent of revenue and, as a result, the Group's order book has now almost recovered to where it was this time last year. The recovery dynamics in organic revenue and order intake have come from across the Group.

 

Notwithstanding the second wave of the pandemic globally, all of our facilities remain open and are delivering to customer requirements, whilst continuing to prioritise the safety of our employees.

 

Margin enhancement

 

We are making good progress with the Group's extended self-help programme, which commenced in the second quarter, with initial headcount reductions completed and transfer activity on schedule to support the site closure timeline. The project is on schedule to deliver the expected £11-12 million of run-rate benefits in 2023.

 

Virolens® update

 

In September we announced that TT had been appointed exclusive manufacturing partner for the commercial launch of Virolens®, a rapid COVID-19 screening device. There remains a wide range of possible outcomes but Virolens® is proceeding through regulatory approvals and devices have been shipped to initial launch customers for operational trials in a number of different jurisdictions.

 

We have also been working to prepare for volume production of Virolens® devices and testing cartridges at our facility in Hartlepool, UK.

 

Torotel acquisition completed

 

On 10 November the Group completed the acquisition of Torotel for an enterprise value of $43.4 million. Torotel is a Kansas, US-based designer and manufacturer of high-reliability power and electro-magnetic assemblies and components designed for harsh environments, primarily for defence markets. The acquisition broadens TT's power electronics capabilities in the US, further increasing its scale in this important market. It adds recurring revenue streams from largely sole source positions on multi-year growth programmes and brings attractive cross-selling opportunities. Work is now underway to integrate Torotel into TT's Power and Connectivity division.

 

Richard Tyson, Chief Executive Officer said:

 

"We are pleased that trading momentum has continued to recover during recent months, with organic revenue trends improving across the Group. We are also continuing to manage the impact of COVID-19 on our people, customers and other stakeholders with all of our facilities open and fully operational.

 

I am also pleased we have completed the acquisition of Torotel, which is a strong strategic fit for TT, increasing both our scale and capabilities in the important US defence market.

 

We are continuing our journey to double-digit margins and expect to see further improvement in trading this year."

 

 

For further information please contact:

 

 

TT Electronics plc

Tel: +44 (0)1932 827 779

Richard Tyson, Chief Executive Officer

Mark Hoad, Chief Financial Officer

Julian Wais, Head of Investor Relations and Communications

 

 

MHP

Tel: +44 (0)20 3128 8100

Tim Rowntree / Rachel Mann

 

 

 

   
 

Notes: 

 

1. Organic growth is stated at constant currency and is calculated by comparing current year actual results to prior year results retranslated at current year actual exchange rates. Organic revenue excludes the impact of acquisitions and disposals.

 

2. TT will announce its full year results on 10 March 2021.

 

About TT Electronics

TT Electronics is a global provider of engineered electronics for performance critical applications.

The company operates in industries where there are structural growth drivers, working with market-leading customers primarily in the industrial, medical, aerospace and defence sectors. Products designed and manufactured include sensors, power management devices and connectivity solutions. TT has design and manufacturing facilities in the UK, US, Sweden and Asia.

The company has three divisions. The Power and Connectivity division designs and manufactures power application products and connectivity devices which enable the capture and wireless transfer of data. We collaborate with our customers to develop innovative solutions to optimise their electronic systems. The Global Manufacturing Solutions division provides manufacturing services and engineering solutions for our product divisions and to customers that often require a lower volume and higher mix of different products. We manufacture complex integrated product assemblies for our customers and provide engineering services including designing testing solutions and value-engineering. The Sensors and Specialist Components division works with customers to develop standard and customised solutions including sensors and power management devices. Our solutions improve the precision, speed and reliability of critical aspects of our customers' applications.

Cautionary statement

This update contains forward-looking statements. These have been made by the directors in good faith based on the information available to them up to the time of their approval of this update. The directors can give no assurance that these expectations will prove to have been correct. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward-looking statements. The directors undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKDBNFBDDDDD
Date   Source Headline
23rd Oct 20242:25 pmRNSHolding(s) in Company
22nd Oct 202412:38 pmRNSHolding(s) in Company
2nd Oct 20247:00 amRNSDirector/PDMR Shareholding
26th Sep 202411:31 amRNSHolding(s) in Company
23rd Sep 20247:00 amRNSHolding(s) in Company
20th Sep 202411:31 amRNSHolding(s) in Company
16th Sep 20247:00 amRNSTrading Update
2nd Sep 20244:43 pmRNSTotal Voting Rights
2nd Sep 20249:00 amRNSNon-Executive Director Succession for AGM 2025
22nd Aug 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSHalf-Year Results
1st Aug 20242:23 pmRNSTotal Voting Rights
29th Jul 20243:44 pmRNSDirector Declaration
24th Jul 202411:39 amRNSDirector Declaration
1st Jul 20243:00 pmRNSTotal Voting Rights
28th Jun 20247:00 amRNSNED Appointment
26th Jun 20242:00 pmRNSNew Reporting Structure
4th Jun 20245:08 pmRNSDirector/PDMR Shareholding
3rd Jun 20242:52 pmRNSTotal Voting Rights
20th May 20245:00 pmRNSHolding(s) in Company
16th May 20243:18 pmRNSHolding(s) in Company
10th May 20243:10 pmRNSAnnual General Meeting Results
10th May 20247:00 amRNSAGM Trading Update
1st May 20242:19 pmRNSBlock listing six monthly return
1st May 20242:16 pmRNSTotal Voting Rights
9th Apr 20247:00 amRNSCapital Markets Event
4th Apr 20245:40 pmRNSAnnual Financial Report
2nd Apr 20247:00 amRNSCompletion of Divestment
19th Mar 20244:44 pmRNSLong Term Incentive Plan
19th Mar 20248:15 amRNSNon-Executive Director Change
15th Mar 20248:30 amRNSDeferred Share Bonus Plan
12th Mar 20249:01 amRNSDeferred Share Bonus Plan
12th Mar 20249:00 amRNSLong Term Incentive Plan
7th Mar 20247:00 amRNSFull Year Results
4th Mar 20247:00 amRNSDivestment of selected business units
1st Mar 20242:25 pmRNSTotal Voting Rights
15th Feb 20243:59 pmRNSTotal Voting Rights
26th Jan 20248:54 amRNSHolding(s) in Company
25th Jan 202411:32 amRNSHolding(s) in Company
22nd Jan 20244:53 pmRNSHolding(s) in Company
3rd Jan 202411:24 amRNSTotal Voting Rights
4th Dec 20239:02 amRNSTotal Voting Rights
24th Nov 202310:36 amRNSDirectorate Change
22nd Nov 20237:00 amRNSTrading Update
15th Nov 20238:36 amRNSBlock Listing Application
3rd Nov 20232:48 pmRNSHolding(s) in Company
30th Oct 20234:45 pmRNSBlock Listing Six Monthly Return
25th Oct 20238:33 amRNSHolding(s) in Company
11th Oct 20238:40 amRNSHolding(s) in Company
2nd Oct 20232:40 pmRNSShare Awards for Incoming Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.